Alkermes Plc
NASDAQ:ALKS

Watchlist Manager
Alkermes Plc Logo
Alkermes Plc
NASDAQ:ALKS
Watchlist
Price: 29.1 USD -0.48% Market Closed
Market Cap: 4.8B USD
Have any thoughts about
Alkermes Plc?
Write Note

Alkermes Plc
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Alkermes Plc
Revenue Peer Comparison

Comparables:
AMRN
PRTA

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Alkermes Plc
NASDAQ:ALKS
Revenue
$1.5B
CAGR 3-Years
10%
CAGR 5-Years
7%
CAGR 10-Years
10%
Amarin Corporation PLC
NASDAQ:AMRN
Revenue
$241m
CAGR 3-Years
-26%
CAGR 5-Years
-8%
CAGR 10-Years
18%
Prothena Corporation PLC
NASDAQ:PRTA
Revenue
$217.3m
CAGR 3-Years
53%
CAGR 5-Years
200%
CAGR 10-Years
16%

Alkermes Plc
Revenue Breakdown

Breakdown by Geography
Alkermes Plc

Total Revenue: 1.7B USD
100%
United States: 1.5B USD
89.7%
Foreign Country Excluding Specified Country: 170.3m USD
10.2%
Ireland: 1.2m USD
0.1%

Breakdown by Segments
Alkermes Plc

Total Revenue: 1.7B USD
100%
Product: 920m USD
55.3%
Vivitrol: 400.4m USD
24.1%
Aristada And Aristada Initio: 327.7m USD
19.7%
L Y B A L V I: 191.9m USD
11.5%
Show More
Show Less

See Also

What is Alkermes Plc's Revenue?
Revenue
1.5B USD

Based on the financial report for Sep 30, 2024, Alkermes Plc's Revenue amounts to 1.5B USD.

What is Alkermes Plc's Revenue growth rate?
Revenue CAGR 10Y
10%

Over the last year, the Revenue growth was -5%. The average annual Revenue growth rates for Alkermes Plc have been 10% over the past three years , 7% over the past five years , and 10% over the past ten years .

Back to Top